Serum bile acids in patients with liver failure supported with a bioartificial liver

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 8, 2002, Pages 1547-1554

  Pazzi, P ^a   Morsiani, E ^a   Vilei, M T ^b   Granato, A ^b   Rozga, J ^c   Demetriou, A A ^c   Muraca, M ^b,d  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; HYDROXYL GROUP;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL LIVER; BILE ACID BLOOD LEVEL; BILE ACID SYNTHESIS; BIOARTIFICIAL ORGAN; BIOREACTOR; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONJUGATION; DISEASE ASSOCIATION; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HYDROPHOBICITY; LIVER FAILURE; LIVER TOXICITY; MALE; MASS SPECTROMETRY; PATHOGENESIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SWINE; BLOOD; HEPATIC ENCEPHALOPATHY; MASS FRAGMENTOGRAPHY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; BILE ACIDS AND SALTS; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER FAILURE; LIVER, ARTIFICIAL; MALE; MASS FRAGMENTOGRAPHY; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MIDDLE AGED;

EID: 0036668714     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01314.x     Document Type: Article

References (44)

1. Extracorporeal liver support: Historical background and critical analysis
2. Review article: The management of acute liver failure
3. Serum bile acids
4. Biochemical assay of serum bile acids: Methods and applications
5. Review article: Liver support system in acute hepatic failure
6. Current status of liver support systems
7. Bioartificial liver support
8. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase 1 clinical trial
9. An interim analysis of a phase II/III prospective randomised, multicenter, controlled trial of the Hepatassist Bioartificial Liver Support System for the treatment of fulminant hepatic failure
10. Automated liver cell processing facilitates large scale isolation and purification of porcine hepatocytes
11. Development of a bioartificial liver: Properties and function of a hollow-fiber module inoculated with liver cells
12. Glyco-7-alpha, 12-alpha-dihydroxy-5-beta-cholanic acid as internal standard for high-pressure liquid chromatographic analysis of conjugated bile acids
13. Performance characteristics of reversed-phase bonded silica cartridges for serum bile acid extraction
14. 22-ursodeoxycholic acid. A unique metabolite of administered ursodeoxycholic acid in rats. Indicating partial β-oxidation as a major pathway for bile acid metabolism
15. Evidence for involvement of oxygen free radicals in bile acid toxicity to isolated rat hepatocytes
16. Increases of intracellular magnesium promote glycodeoxycholate induced apoptosis in rat hepatocytes
17. Cytotoxicity of bile salts against biliary epithelium: A study in isolated bile duct fragments and isolated perfused rat liver
18. Comparison of the effects of bile acids on cell viability and DNA synthesis by rat hepatocytes in primary culture
19. Serum concentrations and excretion of bile acids in cirrhosis
20. Diagnostic value of serum bile acid estimations in liver disease
21. Serum bile acids: Physiological determinants and results in liver disease
22. Cholesterol and bile acid metabolism in moderately advanced. Stable cirrhosis of the liver
23. Cholesterol absorption in cirrhosis: The role of total and individual bile acid pool size
24. Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatographymass spectrometry: Effect of ursodeoxycholic acid treatment
25. Long-term prognostic value of serum bile acids in liver cirrhosis: A prospective study
26. Mechanisms for reduced hepatic clearance and elevated plasma levels of bile acids in cirrhosis. A study in patients with an end-to-side portacaval shunt
27. Selectivity and sensitivity of changes in serum bile acids during induction of cirrhosis in rats
28. Direct measurement of hepatic extraction of chenodeoxycholic and ursodeoxycholic acid in man
29. Direct assessment of the mechanism for a raised serum bile acid level in chronic liver disease
30. Bile acid metabolism in cirrhosis. VI. Sites of blockage in the bile acid pathways to primary bile acids
31. Bile acid metabolism in patients with cirrhosis. I. Kinetic aspects of cholic acid metabolism
32. Bile acid metabolism in patients with cirrhosis. II. Cholic and chenodeoxycholic acid metabolism
33. Lipid absorption, bile acids, and cholesterol metabolism in patients with chronic liver disease
34. Pool size, synthesis, and turnover of sulfated and nonsulfated cholic acid and chenodeoxycholic acid in patients with cirrhosis of the liver
35. The hydrophobic hydrophilic balance of bile salt. Inverse correlation between reverse-phase high performance liquid chromatographic mobilities and micellar cholesterol solubilizing capacities
36. Physico-chemical properties of bile acids and their relationship to biological properties: An overview of the problem
37. Bilirubin-induced apoptosis in cultured rat neural cells is aggravated by chenodeoxycholic acid but prevented by ursodeoxycholic acid
38. Serum, cerebral fluid, and brain levels of bile acids in patients with fulminant liver failure
39. Clinical significance of serum bile acid measurement in liver diseases
40. Ursodeoxycholic acid in cholestasis: Potential mechanisms of action and therapeutic applications
41. Removal of bile acids and bilirubin by plasmaperfusion of U.S.P. charcoal-coated glass beads
42. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure
43. Biochemical assessment and clinical evaluation of a non-ionic adsorbent resin in patients with intractable jaundice
44. In vitro morphological and functional characterization of isolated porcine hepatocytes from extracorporeal liver support: Bile acid uptake and conjugation